These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5385252)

  • 61. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
    Krenzien HN
    Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
    [No Abstract]   [Full Text] [Related]  

  • 62. Elimination of leprosy: forecasts and projections.
    Gupte MD
    Indian J Lepr; 1994; 66(1):19-35. PubMed ID: 7983389
    [No Abstract]   [Full Text] [Related]  

  • 63. Spot test for DDS (diamino diphenyl sulphone) in urine under field conditions.
    Noordeen SK; Balakrishnan S
    Indian J Med Res; 1972 Mar; 60(3):367-71. PubMed ID: 4573555
    [No Abstract]   [Full Text] [Related]  

  • 64. Treatment of leprosy and immunologic considerations.
    Chatterjee BR
    Lepr India; 1981 Apr; 53(2):142-51. PubMed ID: 7253567
    [No Abstract]   [Full Text] [Related]  

  • 65. Multidrug therapy for treatment of paucibacillary leprosy in western Kenya--preliminary communications.
    Orege PA; Obura M; Okelo C; Okuku P; Makokha S; Nyawalo J
    East Afr Med J; 1990 Sep; 67(9):632-9. PubMed ID: 2253572
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Problems of leprosy relapse in China.
    Li HY
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recent changes in leprosy control.
    Sansarricq H
    Lepr Rev; 1983 Jun; Spec No():7-16. PubMed ID: 6350774
    [No Abstract]   [Full Text] [Related]  

  • 68. Polytherapy in multibacillary leprosy patients in Nepal.
    Samuel NM; Samual S; Fairbairn T; Adiga RB
    Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403
    [No Abstract]   [Full Text] [Related]  

  • 69. Prevention and early detection of leprosy in children.
    Dayal R; Bharadwaj VP
    J Trop Pediatr; 1995 Jun; 41(3):132-8. PubMed ID: 7636930
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 71. Leprosy and its chemotherapy.
    Beeching NJ; Ellis CJ
    J Antimicrob Chemother; 1982 Aug; 10(2):81-4. PubMed ID: 6749788
    [No Abstract]   [Full Text] [Related]  

  • 72. Dapsone resistant leprosy, the western Kenya experience.
    Orege PA; Owili DM
    Trop Geogr Med; 1985 Jun; 37(2):139-42. PubMed ID: 4035777
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ten years' leprosy control work in Malaŵi (Central Africa)--I. Methods and outcome after treatment.
    Boerrigter G; Ponnighaus JM
    Lepr Rev; 1986 Sep; 57(3):199-219. PubMed ID: 3784755
    [No Abstract]   [Full Text] [Related]  

  • 74. Primary dapsone-resistant leprosy in San Francisco.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An outbreak of leprosy in a previously unexposed population of eastern New Guinea.
    Stanhope JM; Sturt RJ; Russell DA
    Trans R Soc Trop Med Hyg; 1968; 62(5):700-11. PubMed ID: 5707922
    [No Abstract]   [Full Text] [Related]  

  • 76. Letter: Dapsone dosage and drug resistance.
    Pfaltzgraff RE
    Lepr Rev; 1975 Sep; 46(3):235-8. PubMed ID: 1186417
    [No Abstract]   [Full Text] [Related]  

  • 77. Chemotherapy of leprosy for control programmes: scientific basis and practical application.
    Rees RJ
    Lepr Rev; 1983 Jun; 54(2):81-7. PubMed ID: 6888143
    [No Abstract]   [Full Text] [Related]  

  • 78. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. I. Overview of the study.
    Schreuder PA
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):149-58. PubMed ID: 9728447
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chemoprophylaxis against leprosy with acedapsone. An interim report.
    Noordeen SK; Neelan PN; Munaf A
    Lepr India; 1980 Jan; 52(1):97-103. PubMed ID: 6991817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.